Using PRP and Cord Blood in Treatment of Covid -19
the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19
1 other identifier
interventional
100
1 country
1
Brief Summary
covid - 19 is a critical viral infection that affects humans
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2020
CompletedFirst Posted
Study publicly available on registry
May 19, 2020
CompletedStudy Start
First participant enrolled
May 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedJuly 27, 2020
July 1, 2020
3 months
May 15, 2020
July 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
the number of patients with positive covid 19 who will improve after receiving stem cells
patients with positive covid 19 who will improve after receiving stem cells
2 weeks
Study Arms (3)
patients receiving LGF
ACTIVE COMPARATORpatients not receiving LGF nor PRP
NO INTERVENTIONpatients receiving Platelet rich plasma
ACTIVE COMPARATORInterventions
giving stem cells to patients with covid - 19
Eligibility Criteria
You may qualify if:
- patients with positive covid -19 and has symptoms and isolated in the hospital
You may not qualify if:
- patients with negative test for covid -19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aljazeera( Al Gazeera) hospital
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud Alalfy, PhD
Algezeera hospitaland National Research Centre ,Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2020
First Posted
May 19, 2020
Study Start
May 25, 2020
Primary Completion
August 25, 2020
Study Completion
September 1, 2020
Last Updated
July 27, 2020
Record last verified: 2020-07